23.78k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|The Fight Against COVID19||+0.49%||-||-||-|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|JNJ||Johnson & Johnson||158.38||+3.72||+2.41%||4:00 p.m. EST||10.34M||6.87M||381.27B|
|ABBV||AbbVie Inc.||143.41||+1.02||+0.72%||4:00 p.m. EST||4.90M||4.90M||253.20B|
|PFE||Pfizer Inc.||28.91||-1.56||-5.12%||4:00 p.m. EST||103.62M||30.62M||163.24B|
|SNY||Sanofi||46.72||-0.03||-0.06%||4:00 p.m. EST||1.16M||2.05M||117.56B|
|GILD||Gilead Sciences, Inc.||77.65||+1.05||+1.37%||4:00 p.m. EST||5.40M||5.74M||96.76B|
|REGN||Regeneron Pharmaceuticals, Inc.||814.86||-8.95||-1.09%||4:00 p.m. EST||560.25k||448.00k||88.78B|
|GSK||GSK plc||36.57||+0.58||+1.61%||4:00 p.m. EST||2.55M||3.70M||74.88B|
|TAK||Takeda Pharmaceutical Company Limited||14.17||+0.02||+0.14%||4:00 p.m. EST||830.97k||1.87M||44.50B|
|MRNA||Moderna, Inc.||79.83||+2.13||+2.74%||4:00 p.m. EST||3.96M||4.08M||30.44B|
|BNTX||BioNTech SE||99.4||-1.01||-1.01%||4:00 p.m. EST||802.92k||636.02k||23.83B|
|VIR||Vir Biotechnology, Inc.||9.69||+0.20||+2.11%||4:00 p.m. EST||1.03M||1.46M||1.30B|
|NVAX||Novavax, Inc.||5.57||+0.07||+1.27%||4:00 p.m. EST||6.87M||8.63M||661.66M|
|INO||Inovio Pharmaceuticals, Inc.||0.398||+0.00||+0.96%||4:00 p.m. EST||3.44M||3.53M||108.65M|
California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.
It's surely a bad sign for the US economy, right? Not so fast.
Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil. One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy. Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.